Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licartin + TACE for Unresectable Hepatocellular Carcinoma
NCT00829465Phase 4Completed
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Dec 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of licofelone in hepatocellular carcinoma (HCC), sponsored by Eastern Hepatobiliary Surgery Hospital. Started Dec 2008; status: completed.
02
Drugs
licofelone
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00829465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00829465.